Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 6.03% vs 8.25% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -26.90% vs 31.94% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -28.36% vs 52.92% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 84.21% vs 0.00% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of Fuso Pharmaceutical Industries Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 11.50% vs -17.83% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 6.03% vs 8.25% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 108.12% vs -756.29% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -26.90% vs 31.94% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 116.81% vs -68.10% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -28.36% vs 52.92% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 40.00% vs 28.21% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 84.21% vs 0.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






